Interpreting indicators of iron status during an acute phase response - Lessons from malaria and human immunodeficiency virus

Annals of Clinical Biochemistry

Volumn 45, Issue 1, 2008, Pages 18-32

  Northrop Clewes, Christine A ^a,b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b MRC Human Nutritional Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; HAPTOGLOBIN; HEMOGLOBIN; LACTOFERRIN; OROSOMUCOID; TRANSFERRIN RECEPTOR; FERRITIN; IRON;

ACUTE PHASE RESPONSE; ANEMIA; DISEASE COURSE; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; IRON DEFICIENCY; IRON METABOLISM; MALARIA; OUTCOME ASSESSMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; BLOOD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACUTE-PHASE REACTION; ANIMALS; FERRITINS; HUMANS; IRON; MALARIA;

EID: 40449116524     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2007.007167     Document Type: Review

References (89)

1. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers. Geneva: WHO/UNICEF/UNU, 2001. Report No.: WHO/NHD/01.3
2. Kreuzer KA, Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997;75:179-87
3. World Health Organisation (WHO), Centers for Disease Control and Prevention (CDC). Assessing the Iron Status of Populations: Report of a Joint WHO/CDC Technical Consultation on the Assessment of Iron Status at the Population Level. Geneva, Switzerland: WHO, 2004
4. Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R. Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem 1994;40:768- 73
5. Davidson RJ, Hamilton PJ. High mean red cell volume: its incidence and significance in routine haematology. J Clin Pathol 1978;31:493-8
6. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990;75:1870-6
7. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99:3505-16
8. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9-22
9. Gordon AH, Koy A. The Acute Phase Response to Injury and Infection. The Roles of Interleukin1 and Other Mediators. Amsterdam: Elsevier, 1985
10. Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci 2005;6B:1045-56
11. Dinarello CA. Pathogenesis of fever during hemodilution. Contr Nephrol 1983;36:90-9
12. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 1985;55:91-101
13. Kraft R, Ruchti C, Burkhardt AH, Cottier H. Pathogenic principles in the development of gut-derived infectious-toxic shock (GITS) and multiple organ failure. Curr Stud Hematol Blood Tranfus 1992;59:204-40
14. van Miert ASJPAM. Pro-inflammatory cytokines in a ruminant model: pathophysiology, pharmacological and therapeutic aspects. Vet Quart 1995;175:41-50
15. Fleck A, Myers MA. Diagnostic and prognostic significance of the acute phase proteins. In: Gordon AH, Koj A, eds. The Acute Phase Response to Injury and Infection. Amsterdam: Elsevier Science, 1985:249-71
16. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54
17. Shine B, De Beer FC, Pepys MB. Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981;117:13-23
18. Myers MA, Fleck A, Sampson B, Colley CM, Bent J, Hall G. Early plasma protein and mineral changes after surgery: a two stage process. J Clin Pathol 1984;37:862-6
19. Baynes R, Bezwoda W, Bothwell T, Khan Q, Manssor N. The non-immune inflammatory response: serial changes in plasma iron, iron binding capacity, lactoferrin, ferritin and C-reactive protein. Scand J Clin Lab Invest 1986;46:695-704
20. Vigushin D, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein. J Clin Invest 1993;91:1351-7
21. Drysdale JW, Munro HN. Regulation of synthesis and turnover of ferritin in rat liver. J Biol Chem 1966;241:3630-7
22. Feelders RA, Vreugdenhil G, Eggermont AM, Kuiper-Kramer PA, van Eijk HG, Swaak AJ. Regulation of iron metabolism in the acute phase response: interferon γ- tumour necrosis factor α- induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur J Clin Invest 1998;28:520-7
23. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994;19:1468-75
24. Uchida T, Yamagiwa A, Nakamura K. The effect of interleukin-1 on iron metabolism in rats. Eur J Haematol 1991;46:1-5
25. Hirayama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993;18:874-80
26. Denz H, Huber P, Landmann R, Orth B, Wachter H, Fuchs D. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Haematol 1992;48:244-8
27. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;ii:1434-6
28. Konijn AM, Hershko C. Ferritin synthesis in inflammation 1. Pathogenesis of impaired iron release. Br J Haematol 1977;37:7-16
29. Alvarez-Hernande X, Liceaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22
30. Thurnham DI, Northrop-Clewes CA. Effects of infection on nutritional and immune status. In: Hughes DA, Darlington LG, Bendich A, eds. Diet and Immune Function. Totowa, NJ: Humana Press Inc, 2004:35-63
31. Bullen JJ. The significance of iron in infection. Rev Infect Dis 1981;3:1127-38
32. Farnaud S, Evans RW. Lactoferrin - a multifunctional protein with antimicrobial properties. Mol Immunol 2003;40:395-405
33. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006;108:3204-9
34. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2462-3
35. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Ann Rev Nutr 2006;26:323-42
36. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-8
37. Beisel WR. Infection-induced depression of serum retinol - a component of the acute phase response or a consequence. Am J Clin Nutr 1998;68:993-4
38. Hershko C, Peto TEA, Weatherall DJ. Iron and infection. BMJ 1988;296:660-4
39. Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991;338:907-10
40. Thurnham DI, Northrop-Clewes CA. Infection and the etiology of anemia. In: Kraft R, Zimmermann MB, eds. Nutritional Anemia. Basel: SIGHT AND LIFE Press, 2007:231-56
41. Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hulten L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol 1993;85:787-98
42. Milman N, Byg KE, Ovesen L, Kirchhoff M, Jurgensen KSL. Iron status in Danish women, 1984-1994: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2003;71:51-61
43. Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev 1995;53:246-54
44. Herbert V, Jayatilleke E, Shaw S, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells 1997;15:291-6
45. Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 2003;25:353-7
46. Remacha AF, Sarda MP, Parallada M, Ubeda J, Manteiga R. The role of serum transferrin receptor in the diagnosis of iron deficiency. Haematologica 1998;83:963-6
47. Bultink IE, Lems WF, van de Stadt RJ, et al. Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis. Arthritis Rheumatol 2001;44:979-81
48. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-63
49. Lee E-J, Oh E-J, Park Y-J, Lee H-K, Kim B-K. Soluble transferrin receptor (sTfR), ferritin, and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clin Chem 2002;48:1118-21
50. Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response? Clin Chem 1991;37:484-5
51. Witte DL, Angstadt DS, Davis SH, Schrantz RD. Predicting bone marrow iron stores in anemic patients in a community hospital using ferritin and erythrocyte sedimentation rate. Am J Clin Pathol 1988;90:85-7
52. Coenen JL, van Dieijen-Visser MP, van Pelt J, et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem 1991;37:560-3
53. Baker E, Morgan H. Iron transport. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London, UK: WB, Saunders, 1994:63-95
54. Shih YJ. Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem 1990;265:19077-81
55. Allen J, Backstrom KR, Cooper JA, et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem 1998;44:35-9
56. Kohgo Y, Nishisato T, Kondo H, Tsushima N, Niitsu Y, Urushizaki I. Circulating transferrin receptor in human serum. Br J Haematol 1986;64:277-81
57. Beguin Y, Huebers HA, Josephson B, Finch CA. Transferrin receptors in rat plasma. Proc Nat Acad Sci 1988;85:637-40
58. Virtanen MA, Viinikka LU, Virtanen MKG, et al. Higher concentrations of serum transferrin receptor in children than in adults. Am J Clin Nutr 1999;69:256-60
59. Heubers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102
60. Flowers CH, Skikne BS, Covell AM, Cook JD. The clinical measurement of serum transferrin receptor. J Lab Med 1989;114:368
61. Spivak JL. The blood in systemic disorders. Lancet 2000;355:1707-12
62. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067- 76
63. Nielsen OJ, Andersen LS, Hansen NE, Hansen TM. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis. Scand J Clin Lab Invest 1994;54:75-82
64. Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 2002;17:39-43
65. Stoltzfus RJ, Chwaya HM, Montresor A, Albonico M, Savioli L, Tielsch JM. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J Nutr 2000;130:1724-33
66. Stoltzfus RJ, Chwaya HM, Albonico M, Schulze KJ, Savioli L, Tielsch JM. Serum ferritin, erythrocyte protoporphyrin and hemoglobin are valid indicators of iron status of school children in a malaria-holoendemic population. J Nutr 1997;127:293-8
67. Verhoef H, West CE, Ndeto P, Burema J, Beguin Y, Kok FJ. Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr 2001;74:767-75
68. Rees DC, Williams TN, Maitlans K, Clegg JB, Weatherall DJ. Alpha thalassaemia is associated with increased soluble transferrin receptor levels. Br J Haematol 1998;103:365-9
69. Mockenhaupt FP, May J, Stark K, Falusi AG, Meyer CG, Bienzle U. Serum transferrin receptor levels are increased in asymptomatic and mild Plasmodium falciparum-infection. Haematologica 1999;84:869-73
70. Singhal A, Cook JD, Skikne BS, Thomas P, Serjeant B, Serjeant G. The clinical significance of serum transferrin receptor levels in sickle cell disease. Br J Haematol 1993;84:301-4
71. Menendez C, Quinto LL, Kahigwa E, et al. Effect of malaria on soluble transferrin receptor levels in Tanzanian infants. Am J Trop Med Hyg 2001;65:138-42
72. Odunukwe NN, Salako LA, Okany C, Ibrahim MM. Serum ferritin and other haematological measurements in apparently healthy adults with malaria parasitaemia in Lagos, Nigeria. Trop Med Int Health 2000;5:582-6
73. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 1999;13:943-50
74. Fuchs D, Zangerle R, Artner-Dworzak E, et al. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993;50:90-4
75. Sarcletti M, Quirchmair G, Weiss G, Fuchs D, Zangerle R. Increase of haemoglobin levels by anti-retroviral therapy is associated with a decrease in immune activation. Eur J Haematol 2003;70:17-25
76. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 1999;17:279-87
77. Boelaert JR, Weinberg GA, Weinberg GD. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996;5:36-46
78. Gordeuk VR, Delanghe JR, Langlois MR, Boelaert JR. Iron status and the outcome of HIV infection: an overview. J Clin Virol 2001;20:111-15
79. Melchoir J-C, Niyongabo T, Henzel D, Durack-Brown I, Henri S-C, Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999;15:865-9
80. Lee MH, Means RT. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med 1995;98:566-71
81. Rogers J, Durmowicz G, Kasschau K, et al. A motif within the 50 non-coding regions of acute phase mRNA mediates control of ferritin translation by IL1ß and may contribute to the anemia of chronic disease. Blood 1991;78(suppl 1):361a
82. Jahoor F, Gazzard B, Phillips G, et al. The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am J Physiol Endocrinol Metab 1999;276:E1092-8
83. Friis H, Gomo E, Kastel P, et al. HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001;73:1066-73
84. Jahoor F, Abramson S, Heird WC. The protein metabolic response to HIV infection in young children. Am J Clin Nutr 2003;78:182-9
85. Hommes MJ, Romijn JA, Endert E, Sauerwein HP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311-15
86. Ellaurie M, Rubinstein A. Ferritin levels in pediatric HIV-1 infection. Acta Paediatr 1994;83:1035-7
87. Thurnham DI, Mburu ASW, Mwaniki DL, de Wagt A. Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 2005;64:1-9
88. Pantopoulos K, Weiss G, Hentze MW. Nitric oxide and the post-transcriptional control of cellular iron traffic. Trends Cell Biol 1994;4:82-6
89. Savarino A, Calosso L, Piragino A, et al. Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1. Cell Biochem Funct 1999;17:47-55